Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host

Background Clostridium difficile infection (CDI) is a serious threat for an aging population. Using an aged mouse model, we evaluated the effect of age and the roles of innate immunity and intestinal microbiota. Methods Aged (18 months) and young (8 weeks) mice were infected with C difficile, and disease severity, immune response, and intestinal microbiome were compared. The same experiment was repeated with intestinal microbiota exchange between aged and young mice before infection. Results Higher mortality was observed in aged mice with weaker neutrophilic mobilization in blood and intestinal tissue and depressed proinflammatory cytokines in early infection. Microbiota exchange improved survival and early immune response in aged mice. Microbiome analysis revealed that aged mice have significant deficiencies in Bacteroidetes phylum and, specifically, Bacteroides, Alistipes, and rc4-4 genera, which were replenished by cage switching. Conclusions Microbiota-dependent alteration in innate immune response early on during infection may explain poor outcome in aged host with CDI.

[1]  Michael Shaffer,et al.  Diverse Intestinal Bacteria Contain Putative Zwitterionic Capsular Polysaccharides with Anti-inflammatory Properties. , 2016, Cell host & microbe.

[2]  L. Erickson,et al.  Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection. , 2016, The Journal of infectious diseases.

[3]  K. High,et al.  Older Is Not Wiser, Immunologically Speaking: Effect of Aging on Host Response to Clostridium difficile Infections. , 2016, The journals of gerontology. Series A, Biological sciences and medical sciences.

[4]  S. Dowd,et al.  Pglyrp-Regulated Gut Microflora Prevotella falsenii, Parabacteroides distasonis and Bacteroides eggerthii Enhance and Alistipes finegoldii Attenuates Colitis in Mice , 2016, PloS one.

[5]  Chris Sander,et al.  Precision microbiome restoration of bile acid-mediated resistance to Clostridium difficile , 2014, Nature.

[6]  Thomas B. Clarke.  Early Innate Immunity to Bacterial Infection in the Lung Is Regulated Systemically by the Commensal Microbiota via Nod-Like Receptor Ligands , 2014, Infection and Immunity.

[7]  Patrick D. Schloss,et al.  Microbiome Data Distinguish Patients with Clostridium difficile Infection and Non-C. difficile-Associated Diarrhea from Healthy Controls , 2014, mBio.

[8]  Kevin M. D'Auria,et al.  In Vivo Physiological and Transcriptional Profiling Reveals Host Responses to Clostridium difficile Toxin A and Toxin B , 2013, Infection and Immunity.

[9]  Elena Deych,et al.  Markers of intestinal inflammation, not bacterial burden, correlate with clinical outcomes in Clostridium difficile infection. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[10]  Matthew J. Hamilton,et al.  High-throughput DNA sequence analysis reveals stable engraftment of gut microbiota following transplantation of previously frozen fecal bacteria , 2013, Gut microbes.

[11]  R. Guerrant,et al.  Vancomycin Treatment's Association with Delayed Intestinal Tissue Injury, Clostridial Overgrowth, and Recurrence of Clostridium difficile Infection in Mice , 2012, Antimicrobial Agents and Chemotherapy.

[12]  E. Pamer,et al.  Critical Role for MyD88-Mediated Neutrophil Recruitment during Clostridium difficile Colitis , 2012, Infection and Immunity.

[13]  G. Núñez,et al.  Nucleotide-Binding Oligomerization Domain 1 Mediates Recognition of Clostridium difficile and Induces Neutrophil Recruitment and Protection against the Pathogen , 2011, The Journal of Immunology.

[14]  Guang-xi Li,et al.  Clinical practice guidelines for Clostridium difficile infection in adults:2010 update by the Society for Healthcare Epidemiology of America(SHEA)and the Infectious Diseases Society of America(IDSA) , 2011 .

[15]  A. Manges,et al.  Comparative metagenomic study of alterations to the intestinal microbiota and risk of nosocomial Clostridum difficile-associated disease. , 2010, The Journal of infectious diseases.

[16]  R. Guerrant,et al.  Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain. , 2010, The Journal of infectious diseases.

[17]  Jeffrey N. Weiser,et al.  Recognition of Peptidoglycan from the Microbiota by Nod1 Enhances Systemic Innate Immunity , 2010, Nature Medicine.

[18]  D. Gerding,et al.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults : 2010 Update by the Society for Healthcare Epidemiology of America ( SHEA ) and the Infectious Diseases Society of America , 2010 .

[19]  D. Yokoe,et al.  Clinical Risk Factors for Severe Clostridium difficile–associated Disease , 2009, Emerging infectious diseases.

[20]  Jeffrey D Goldsmith,et al.  A mouse model of Clostridium difficile-associated disease. , 2008, Gastroenterology.

[21]  O. Lesur,et al.  Impact of Emergency Colectomy on Survival of Patients With Fulminant Clostridium difficile Colitis During an Epidemic Caused by a Hypervirulent Strain , 2007, Annals of surgery.

[22]  J. Stockman.  A Predominantly Clonal Multi-Institutional Outbreak of Clostridium difficile—Associated Diarrhea With High Morbidity and Mortality , 2007 .

[23]  L. Valiquette,et al.  Mortality attributable to nosocomial Clostridium difficile–associated disease during an epidemic caused by a hypervirulent strain in Quebec , 2005, Canadian Medical Association Journal.

[24]  M. Mcmurdo,et al.  Comparison of Compositions and Metabolic Activities of Fecal Microbiotas in Young Adults and in Antibiotic-Treated and Non-Antibiotic-Treated Elderly Subjects , 2004, Applied and Environmental Microbiology.

[25]  G. Macfarlane,et al.  Changes in predominant bacterial populations in human faeces with age and with Clostridium difficile infection. , 2002, Journal of medical microbiology.

[26]  C. Kelly,et al.  Clostridium difficile infection. , 2015, The New England journal of medicine.

[27]  R. Guerrant,et al.  Fecal lactoferrin, interleukin-1beta, and interleukin-8 are elevated in patients with severe Clostridium difficile colitis , 1997, Clinical and diagnostic laboratory immunology.

[28]  S. Borriello,et al.  An in-vitro model of colonisation resistance to Clostridium difficile infection. , 1986, Journal of medical microbiology.